BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28806363)

  • 41. Effectiveness of residential treatment services for veterans with substance use disorders: A propensity score matching evaluation.
    Dams GM; Ketchen BR; Burden JL; Smith NB
    Drug Alcohol Depend; 2024 Feb; 255():111081. PubMed ID: 38211367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Service utilization among veterans with schizophrenia and a comorbid anxiety disorder.
    Birgenheir DG; Ganoczy D; Bowersox NW
    Psychiatr Serv; 2014 Nov; 65(11):1354-9. PubMed ID: 25022515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence-based screening, diagnosis, and treatment of substance use disorders among veterans and military service personnel.
    Hawkins EJ; Grossbard J; Benbow J; Nacev V; Kivlahan DR
    Mil Med; 2012 Aug; 177(8 Suppl):29-38. PubMed ID: 22953439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic specificity and mental health service utilization among veterans with newly diagnosed anxiety disorders.
    Barrera TL; Mott JM; Hundt NE; Mignogna J; Yu HJ; Stanley MA; Cully JA
    Gen Hosp Psychiatry; 2014; 36(2):192-8. PubMed ID: 24268573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Individualized Addictions Consultation Team Residential Program: A Creative Solution for Integrating Care for Veterans With Substance Use Disorders Too Complex for Other Residential Treatment Programs.
    Keating S; Larsen SE; Collingwood J; Smith HM
    J Dual Diagn; 2021; 17(2):172-179. PubMed ID: 33583351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records.
    Hasin DS; Fink DS; Olfson M; Saxon AJ; Malte C; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Livne O; Mannes ZL; Sherman SE; Wall MM
    Drug Alcohol Depend; 2022 May; 234():109383. PubMed ID: 35279457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trauma in Veterans With Substance Use Disorder: Similar Treatment Need Among Urban and Rural Residents.
    Young LB; Timko C; Tyler KA; Grant KM
    J Rural Health; 2017 Jun; 33(3):314-322. PubMed ID: 27504603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substance use comorbidity among veterans with posttraumatic stress disorder and other psychiatric illness.
    Petrakis IL; Rosenheck R; Desai R
    Am J Addict; 2011; 20(3):185-9. PubMed ID: 21477045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The 3-Year Course of Multiple Substance Use Disorders in the United States: A National Longitudinal Study.
    McCabe SE; West BT
    J Clin Psychiatry; 2017 May; 78(5):e537-e544. PubMed ID: 28406266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of nursing home admission in association with mental illness nationally in the Department of Veterans Affairs.
    Miller EA; Rosenheck RA
    Med Care; 2006 Apr; 44(4):343-51. PubMed ID: 16565635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study.
    Iheanacho T; Issa M; Marienfeld C; Rosenheck R
    Drug Alcohol Depend; 2013 Sep; 132(1-2):122-6. PubMed ID: 23434041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Blanco C; Alegría AA; Liu SM; Secades-Villa R; Sugaya L; Davies C; Nunes EV
    J Clin Psychiatry; 2012 Jun; 73(6):865-73. PubMed ID: 22480900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mental disorders and quality of diabetes care in the veterans health administration.
    Desai MM; Rosenheck RA; Druss BG; Perlin JB
    Am J Psychiatry; 2002 Sep; 159(9):1584-90. PubMed ID: 12202281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and psychological impact of sailing adventure therapy among Veterans with substance use disorders.
    Marchand WR; Klinger W; Block K; VerMerris S; Herrmann TS; Johnson C; Shubin E; Sheppard S
    Complement Ther Med; 2018 Oct; 40():42-47. PubMed ID: 30219467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence, predictors, and service utilization of patients with recurrent use of Veterans Affairs substance use disorder specialty care.
    Hawkins EJ; Malte CA; Baer JS; Kivlahan DR
    J Subst Abuse Treat; 2012 Sep; 43(2):221-30. PubMed ID: 22197302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of general medical services by VA patients with psychiatric disorders.
    Cradock-O'Leary J; Young AS; Yano EM; Wang M; Lee ML
    Psychiatr Serv; 2002 Jul; 53(7):874-8. PubMed ID: 12096172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Health service use among persons with comorbid bipolar and substance use disorders.
    Verduin ML; Carter RE; Brady KT; Myrick H; Timmerman MA
    Psychiatr Serv; 2005 Apr; 56(4):475-80. PubMed ID: 15812100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Violent and nonviolent suicide in veterans with substance-use disorders.
    Ilgen MA; Conner KR; Valenstein M; Austin K; Blow FC
    J Stud Alcohol Drugs; 2010 Jul; 71(4):473-9. PubMed ID: 20553655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Staff Perceptions of Substance Use Disorder Treatment in VA Primary Care-Mental Health Integrated Clinics.
    Zubkoff L; Shiner B; Watts BV
    J Subst Abuse Treat; 2016 Nov; 70():44-49. PubMed ID: 27692187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health problems of substance-dependent veterans with and those without trauma history.
    Tate SR; Norman SB; McQuaid JR; Brown SA
    J Subst Abuse Treat; 2007 Jul; 33(1):25-32. PubMed ID: 17588486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.